These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 487806)

  • 1. Salpingitis associated with the presence of nonmedicated IUDs.
    Maqueo MT; Calderon JJ; Guerra AZ
    Contraception; 1979 Jun; 19(6):539-42. PubMed ID: 487806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological and histological findings in the fallopian tubes of women using various contraceptive methods.
    Collins JA; Gillett PG; Perlin IA; Embil JA; Zayid I; Richards G; Kirk ME
    Contraception; 1984 Nov; 30(5):457-66. PubMed ID: 6394206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IUD and salpingitis: a prospective study of pathomorphological changes in the oviducts in IUD-users.
    Beerthuizen RJ; Van Wijck JA; Eskes TK; Vermeulen AH; Vooijs GP
    Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):31-41. PubMed ID: 7060816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tubal infertility in relation to the use of an intrauterine device.
    Daling JR; Weiss NS; Metch BJ; Chow WH; Soderstrom RM; Moore DE; Spadoni LR; Stadel BV
    N Engl J Med; 1985 Apr; 312(15):937-41. PubMed ID: 3974683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic salpingitis in intrauterine contraceptive device users.
    Ghosh K; Gupta I; Gupta SK
    Asia Oceania J Obstet Gynaecol; 1989 Mar; 15(1):37-40. PubMed ID: 2735840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic actinomycosis and usage of intrauterine contraceptive devices.
    Kelly J; Aaron J
    Yale J Biol Med; 1982; 55(5-6):453-61. PubMed ID: 7183022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
    Guderian AM; Trobough GE
    Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ characterization of leukocytes in the fallopian tube in women with or without an intrauterine contraceptive device.
    Wollen AL; Sandvei R; Mørk S; Marandon JL; Matre R
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):103-12. PubMed ID: 8116347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the IUD a risk to the future fertility of nulliparas?].
    Caspard H; Spira A
    Cah Sexol Clin; 1987; 13(80):27-9. PubMed ID: 12283161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-uterine contraceptive devices (IUDs) in relation to uterine histology and microbiology.
    Kajanoja P; Lång B; Wahlström T
    Acta Obstet Gynecol Scand; 1987; 66(5):445-9. PubMed ID: 3425246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salpingitis: a frequent response to intrauterine contraception.
    Smith MR; Soderstrom R
    J Reprod Med; 1976 Apr; 16(4):159-62. PubMed ID: 1263179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum contraception.
    Edelman DA; Goldsmith A; Shelton JD
    Int J Gynaecol Obstet; 1981 Aug; 19(4):305-11. PubMed ID: 6119259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubal infertility and the intrauterine device.
    Cramer DW; Schiff I; Schoenbaum SC; Gibson M; Belisle S; Albrecht B; Stillman RJ; Berger MJ; Wilson E; Stadel BV
    N Engl J Med; 1985 Apr; 312(15):941-7. PubMed ID: 3974684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine device and upper-genital-tract infection.
    Grimes DA
    Lancet; 2000 Sep; 356(9234):1013-9. PubMed ID: 11041414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to conception after IUD removal: importance of duration of use, IUD type, pelvic inflammatory disease and age.
    Andolsek L; Teeter RA; Kozuh-Novak M; Wheeler R; Fortney JA; Rosenberg MJ
    Int J Gynaecol Obstet; 1986 Jun; 24(3):217-23. PubMed ID: 2880761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of pelvic inflammatory disease among users of intrauterine devices, irrespective of previous pregnancy.
    Osser S; Liedholm P; Sjöberg NO
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):864-7. PubMed ID: 7468673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New IPPF statement on breastfeeding, fertility and post-partum contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The localization and concentration of copper in the fallopian tube in women with or without an intrauterine contraceptive device.
    Wollen AL; Sandvei R; Skare A; Justesen NP
    Acta Obstet Gynecol Scand; 1994 Mar; 73(3):195-9. PubMed ID: 8122497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.